• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.01% Nasdaq Up0.26%

    Titan Pharmaceuticals Inc. (TTNP)

    4.44 Up 0.20(4.72%) Nov 25, 4:00PM EST
    ProfileGet Profile for:
    Titan Pharmaceuticals Inc.
    400 Oyster Point Boulevard
    Suite 505
    South San Francisco, CA 94080
    United States - Map
    Phone: 650-244-4990
    Fax: 650-244-4956
    Website: http://www.titanpharm.com

    Index Membership:N/A
    Full Time Employees:13

    Business Summary 

    Titan Pharmaceuticals, Inc., a specialty pharmaceutical company, develops proprietary therapeutics for the treatment of serious medical disorders in the United States. The company is developing Probuphine for the long term maintenance treatment of opioid dependence. Its Probuphine is designed to maintain a stable, around the clock blood level of the medicine buprenorphine in patients for six months following a single treatment; and utilizes ProNeura, a novel, proprietary, and long-term drug delivery technology. The company’s ProNeura is also used in developing products for the treatment of other chronic conditions, such as Parkinson’s disease. It is also developing Fanapt (iloperidone), an atypical antipsychotic for the treatment of schizophrenia. The company was founded in 1992 and is based in South San Francisco, California.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Titan Pharmaceuticals Inc.

    Key Executives 
    Dr. Marc Rubin M.D., 60
    Exec. Chairman and Member of Exec. Committee
    Mr. Sunil Bhonsle , 65
    Pres, Sec. and Director
    Dr. Katherine L. Beebe Ph.D.,
    Chief Devel. Officer and Exec. VP
    Brian E. Crowley ,
    VP of Fin.
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders